+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Nanotechnology in Drug Delivery · Registering as Listener

ICNDD
📅 4 – 5 Jan 2027 📍 Vancouver, Canada 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Nanotechnology in Drug Delivery
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 16

This track focuses on the latest advancements in the design and optimization of nano-drug delivery systems. Researchers are invited to present their findings on novel formulations and methodologies that enhance therapeutic efficacy.

This session will explore various nanoparticle formulations aimed at targeted drug delivery, particularly in cancer therapy. Discussions will include the mechanisms of action and the effectiveness of these formulations in clinical settings.

This track examines the role of smart materials in enhancing drug delivery systems through responsive and adaptive mechanisms. Contributions will highlight the integration of nanotechnology with smart materials for improved therapeutic outcomes.

This session will delve into the latest developments in gene delivery systems utilizing nanotechnology. Researchers will discuss the optimization and adaptation of these systems for various therapeutic applications.

This track focuses on the innovative strategies for the delivery of small interfering RNA using nanoparticles. Presentations will cover the design, efficacy, and potential clinical applications of siRNA delivery systems.

This session will explore the use of nanoparticles in targeting angiogenesis, a critical process in tumor growth. Researchers will present their findings on the mechanisms and effectiveness of nanoparticle-based therapies.

This track addresses the application of nanosystems in managing inflammatory diseases. Contributions will focus on the design and efficacy of nanoparticle-based therapies in modulating inflammatory responses.

This session will investigate the toxicological effects and hazards associated with nanoparticles in drug delivery. Researchers will present evidence and discuss the implications of nanoparticle toxicity on health and safety.

This track focuses on the identification and targeting of cellular and intracellular sites for nanoparticle delivery. Discussions will include strategies to enhance cellular uptake and therapeutic efficacy.

This session will explore various routes of nano-drug delivery, including oral, intravenous, and localized delivery systems. Researchers are encouraged to share insights on the advantages and limitations of each route.

This track will address the regulatory and ethical challenges associated with the development and application of nanotechnology in drug delivery. Discussions will focus on ensuring safety and efficacy in clinical practice.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED